pCDNA3-HA-HA-humanCMYC Citations (9)
Originally described in: The Interaction of Myc with Miz1 Defines Medulloblastoma Subgroup Identity.Vo BT, Wolf E, Kawauchi D, Gebhardt A, Rehg JE, Finkelstein D, Walz S, Murphy BL, Youn YH, Han YG, Eilers M, Roussel MF Cancer Cell. 2016 Jan 11;29(1):5-16. doi: 10.1016/j.ccell.2015.12.003. PubMed Journal
Articles Citing pCDNA3-HA-HA-humanCMYC
| Articles |
|---|
| Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth. Mukhopadhyay A, Hanold LE, Thayele Purayil H, Gisemba SA, Senadheera SN, Aldrich JV. Cancer Biol Ther. 2017 Aug 3;18(8):571-583. doi: 10.1080/15384047.2017.1345384. Epub 2017 Jul 10. PubMed |
METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m(6)A Modification.
Weng H, Huang H, Wu H, Qin X, Zhao BS, Dong L, Shi H, Skibbe J, Shen C, Hu C, Sheng Y, Wang Y, Wunderlich M, Zhang B, Dore LC, Su R, Deng X, Ferchen K, Li C, Sun M, Lu Z, Jiang X, Marcucci G, Mulloy JC, Yang J, Qian Z, Wei M, He C, Chen J.
Cell Stem Cell. 2018 Feb 1;22(2):191-205.e9. doi: 10.1016/j.stem.2017.11.016. Epub 2017 Dec 28.
PubMed
Associated Plasmids |
| IRE1alpha-XBP1s pathway promotes prostate cancer by activating c-MYC signaling. Sheng X, Nenseth HZ, Qu S, Kuzu OF, Frahnow T, Simon L, Greene S, Zeng Q, Fazli L, Rennie PS, Mills IG, Danielsen H, Theis F, Patterson JB, Jin Y, Saatcioglu F. Nat Commun. 2019 Jan 24;10(1):323. doi: 10.1038/s41467-018-08152-3. PubMed |
| The F-box protein FBXL16 up-regulates the stability of C-MYC oncoprotein by antagonizing the activity of the F-box protein FBW7. Morel M, Shah KN, Long W. J Biol Chem. 2020 Jun 5;295(23):7970-7980. doi: 10.1074/jbc.RA120.012658. Epub 2020 Apr 28. PubMed |
| Spermine synthase and MYC cooperate to maintain colorectal cancer cell survival by repressing Bim expression. Guo Y, Ye Q, Deng P, Cao Y, He D, Zhou Z, Wang C, Zaytseva YY, Schwartz CE, Lee EY, Mark Evers B, Morris AJ, Liu S, She QB. Nat Commun. 2020 Jun 26;11(1):3243. doi: 10.1038/s41467-020-17067-x. PubMed |
| N(6) -methyladenosine modification of lncRNA Pvt1 governs epidermal stemness. Lee J, Wu Y, Harada BT, Li Y, Zhao J, He C, Ma Y, Wu X. EMBO J. 2021 Apr 15;40(8):e106276. doi: 10.15252/embj.2020106276. Epub 2021 Mar 17. PubMed |
| mTORC1 promotes cell growth via m(6)A-dependent mRNA degradation. Cho S, Lee G, Pickering BF, Jang C, Park JH, He L, Mathur L, Kim SS, Jung S, Tang HW, Monette S, Rabinowitz JD, Perrimon N, Jaffrey SR, Blenis J. Mol Cell. 2021 May 20;81(10):2064-2075.e8. doi: 10.1016/j.molcel.2021.03.010. Epub 2021 Mar 22. PubMed |
| Aurora kinase A inhibition reverses the Warburg effect and elicits unique metabolic vulnerabilities in glioblastoma. Nguyen TTT, Shang E, Shu C, Kim S, Mela A, Humala N, Mahajan A, Yang HW, Akman HO, Quinzii CM, Zhang G, Westhoff MA, Karpel-Massler G, Bruce JN, Canoll P, Siegelin MD. Nat Commun. 2021 Sep 1;12(1):5203. doi: 10.1038/s41467-021-25501-x. PubMed |
| Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC. Sena LA, Kumar R, Sanin DE, Thompson EA, Rosen DM, Dalrymple SL, Antony L, Yang Y, Gomes-Alexandre C, Hicks JL, Jones T, Bowers KA, Eskra JN, Meyers J, Gupta A, Skaist A, Yegnasubramanian S, Luo J, Brennen WN, Kachhap SK, Antonarakis ES, De Marzo AM, Isaacs JT, Markowski MC, Denmeade SR. J Clin Invest. 2022 Dec 1;132(23):e162396. doi: 10.1172/JCI162396. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.